(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] CTD PMID:31150632 1,2-naphthoquinone multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 1, 2-naphthoquinone] CTD PMID:23295225 1,4-dithiothreitol multiple interactions ISO RGD:737546 6480464 Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 1,4-naphthoquinone multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1, 4-naphthoquinone] CTD PMID:23295225 13-dihydrodaunorubicin multiple interactions ISO RGD:737546 6480464 [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... CTD PMID:20670211 , PMID:25541467 17alpha-ethynylestradiol increases expression ISO RGD:737547 6480464 Ethinyl Estradiol results in increased expression of CBR1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:737547 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBR1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:737547 6480464 Ethinyl Estradiol affects the expression of CBR1 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737547 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CBR1 mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBR1 mRNA CTD PMID:16214954 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737547 6480464 Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA CTD PMID:20702594 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CBR1 protein CTD PMID:19492234 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737547 6480464 Tetrachlorodibenzodioxin results in increased expression of CBR1 mRNA CTD PMID:18796159 , PMID:19933214 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 2-acetamidofluorene increases expression ISO RGD:737547 6480464 2-Acetylaminofluorene results in increased expression of CBR1 mRNA CTD PMID:21607683 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:737546 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of CBR1 protein CTD PMID:32044396 2-hydroxypropanoic acid decreases expression ISO RGD:737546 6480464 Lactic Acid results in decreased expression of CBR1 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl affects expression ISO RGD:737547 6480464 3 more ... CTD PMID:20702594 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:737546 6480464 Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] more ... CTD PMID:11306090 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases metabolic processing ISO RGD:737546 6480464 CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11306090 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of CBR1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CBR1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CBR1 mRNA CTD PMID:19483382 9,10-phenanthroquinone increases metabolic processing ISO RGD:737546 6480464 CBR1 protein results in increased metabolism of 9, 10-phenanthrenequinone CTD PMID:29108775 9,10-phenanthroquinone multiple interactions ISO RGD:737546 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 , PMID:23295225 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of CBR1 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CBR1 mRNA CTD PMID:16483693 andrographolide multiple interactions ISO RGD:737547 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA CTD PMID:19737545 antimonite multiple interactions ISO RGD:737546 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 antimycin A decreases expression ISO RGD:737546 6480464 Antimycin A results in decreased expression of CBR1 mRNA CTD PMID:33512557 aristolochic acid increases expression ISO RGD:737546 6480464 aristolochic acid I results in increased expression of CBR1 protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:737546 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 arsenous acid increases expression ISO RGD:737546 6480464 Arsenic Trioxide results in increased expression of CBR1 mRNA CTD PMID:22719067 arsenous acid decreases response to substance ISO RGD:737546 6480464 CBR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22719067 atrazine decreases expression ISO RGD:737546 6480464 Atrazine results in decreased expression of CBR1 mRNA CTD PMID:22378314 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of CBR1 mRNA CTD PMID:19483382 benzo[a]pyrene increases expression ISO RGD:737546 6480464 Benzo(a)pyrene results in increased expression of CBR1 mRNA, Benzo(a)pyrene results in increased expression of CBR1 protein CTD PMID:22531821 benzo[a]pyrene decreases methylation ISO RGD:737546 6480464 Benzo(a)pyrene results in decreased methylation of CBR1 exon CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:737547 6480464 [lipopolysaccharide, E coli O55-B5 co-treated with Benzo(a)pyrene] affects the expression of CBR1 mRNA CTD PMID:28987381 benzo[a]pyrene increases expression ISO RGD:737547 6480464 Benzo(a)pyrene results in increased expression of CBR1 mRNA CTD PMID:19770486 more ... beta-naphthoflavone increases expression ISO RGD:737546 6480464 beta-Naphthoflavone results in increased expression of CBR1 mRNA CTD PMID:17569794 , PMID:19737606 beta-naphthoflavone multiple interactions ISO RGD:737547 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CBR1 mRNA CTD PMID:19737545 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of CBR1 mRNA CTD PMID:16648578 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA CTD PMID:26496021 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CBR1 mRNA CTD PMID:25181051 butylated hydroxyanisole increases expression ISO RGD:737546 6480464 Butylated Hydroxyanisole results in increased expression of CBR1 mRNA, Butylated Hydroxyanisole results in increased expression of CBR1 protein CTD PMID:23247010 captan increases expression ISO RGD:737547 6480464 Captan results in increased expression of CBR1 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:737546 6480464 Carbamazepine affects the expression of CBR1 mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO RGD:737547 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chenodeoxycholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 chloroprene increases expression ISO RGD:737547 6480464 Chloroprene results in increased expression of CBR1 mRNA CTD PMID:23125180 ciprofibrate increases expression ISO RGD:737547 6480464 ciprofibrate results in increased expression of CBR1 mRNA CTD PMID:12771043 cisplatin multiple interactions ISO RGD:737546 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CBR1 mRNA CTD PMID:27392435 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CBR1 mRNA CTD PMID:19483382 Clofop increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of fenofibric acid CTD PMID:27599626 coumarin increases expression EXP 6480464 coumarin results in increased expression of CBR1 mRNA CTD PMID:18480146 coumestrol increases expression ISO RGD:737546 6480464 Coumestrol results in increased expression of CBR1 mRNA CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CBR1 mRNA CTD PMID:26577399 curcumin multiple interactions ISO RGD:737546 6480464 [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... CTD PMID:25541467 cyclosporin A decreases expression ISO RGD:737547 6480464 Cyclosporine results in decreased expression of CBR1 mRNA CTD PMID:19770486 cyclosporin A multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 cyclosporin A decreases expression ISO RGD:737546 6480464 Cyclosporine results in decreased expression of CBR1 mRNA CTD PMID:20106945 , PMID:25562108 daunorubicin increases metabolic processing ISO RGD:737546 6480464 CBR1 protein results in increased metabolism of Daunorubicin, CBR1 results in increased metabolism of Daunorubicin CTD PMID:20670211 , PMID:30849340 daunorubicin increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of Daunorubicin CTD PMID:18579125 , PMID:25541467 daunorubicin decreases metabolic processing ISO RGD:737546 6480464 CBR1 gene SNP results in decreased metabolism of Daunorubicin CTD PMID:19204081 daunorubicin multiple interactions ISO RGD:737546 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:20670211 more ... Deguelin decreases expression ISO RGD:737546 6480464 deguelin results in decreased expression of CBR1 mRNA CTD PMID:33512557 deoxycholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 dexamethasone decreases expression ISO RGD:737547 6480464 Dexamethasone results in decreased expression of CBR1 mRNA CTD PMID:22733784 diarsenic trioxide decreases response to substance ISO RGD:737546 6480464 CBR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22719067 diarsenic trioxide increases expression ISO RGD:737546 6480464 Arsenic Trioxide results in increased expression of CBR1 mRNA CTD PMID:22719067 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CBR1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:737547 6480464 Dibutyl Phthalate results in decreased expression of CBR1 mRNA CTD PMID:17361019 , PMID:21266533 diclofenac affects expression ISO RGD:737546 6480464 Diclofenac affects the expression of CBR1 mRNA CTD PMID:24752500 diethyl maleate increases expression ISO RGD:737547 6480464 diethyl maleate results in increased expression of CBR1 mRNA CTD PMID:25270620 dioxygen multiple interactions ISO RGD:737546 6480464 3 more ... CTD PMID:24975222 dioxygen multiple interactions ISO RGD:737547 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBR1 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:737546 6480464 Oxygen deficiency results in increased expression of CBR1 mRNA, Oxygen deficiency results in increased expression of CBR1 protein CTD PMID:24975222 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:737546 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CBR1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:737546 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 doxorubicin affects reduction ISO RGD:737546 6480464 CBR1 protein affects the reduction of Doxorubicin CTD PMID:18635746 doxorubicin increases response to substance ISO RGD:737547 6480464 CBR1 protein results in increased susceptibility to Doxorubicin CTD PMID:11016643 , PMID:14583452 doxorubicin multiple interactions ISO RGD:737546 6480464 [resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin CTD PMID:24064738 doxorubicin increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of Doxorubicin CTD PMID:18755171 doxorubicin increases expression ISO RGD:737546 6480464 Doxorubicin results in increased expression of CBR1 protein CTD PMID:18755171 doxorubicin decreases metabolic processing ISO RGD:737546 6480464 CBR1 gene SNP results in decreased metabolism of Doxorubicin CTD PMID:19204081 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CBR1 mRNA CTD PMID:29391264 etacrynic acid multiple interactions ISO RGD:737546 6480464 Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 ethanol affects expression ISO RGD:737547 6480464 Ethanol affects the expression of CBR1 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:737547 6480464 Ethanol results in increased expression of CBR1 mRNA CTD PMID:30319688 fenpyroximate decreases expression ISO RGD:737546 6480464 fenpyroximate results in decreased expression of CBR1 mRNA CTD PMID:33512557 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CBR1 mRNA CTD PMID:24136188 folpet increases expression ISO RGD:737547 6480464 folpet results in increased expression of CBR1 mRNA CTD PMID:31558096 furan increases expression EXP 6480464 furan results in increased expression of CBR1 mRNA CTD PMID:25539665 furan increases expression ISO RGD:737547 6480464 furan results in increased expression of CBR1 mRNA CTD PMID:24183702 genistein increases expression ISO RGD:737546 6480464 Genistein results in increased expression of CBR1 mRNA CTD PMID:16705744 genistein multiple interactions ISO RGD:737546 6480464 [Genistein co-treated with NADP] binds to CBR1 protein CTD PMID:25526675 glycochenodeoxycholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 griseofulvin affects expression ISO RGD:737547 6480464 Griseofulvin affects the expression of CBR1 mRNA CTD PMID:12735108 hexane-2,3-dione increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of 2, 3-hexanedione CTD PMID:25541467 , PMID:30849340 hexane-2,3-dione multiple interactions ISO RGD:737546 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased reduction of 2 more ... CTD PMID:23295225 more ... hydrazine increases expression ISO RGD:737547 6480464 hydrazine results in increased expression of CBR1 mRNA CTD PMID:15282401 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CBR1 mRNA CTD PMID:18299717 isatin multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of Isatin] CTD PMID:23295225 Isoxanthohumol multiple interactions ISO RGD:737546 6480464 isoxanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 ivermectin decreases expression ISO RGD:737546 6480464 Ivermectin results in decreased expression of CBR1 protein CTD PMID:32959892 L-1,4-dithiothreitol multiple interactions ISO RGD:737546 6480464 Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of CBR1 mRNA CTD PMID:19483382 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CBR1 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:737546 6480464 CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] more ... CTD PMID:25818598 m-xylene increases expression EXP 6480464 3-xylene results in increased expression of CBR1 mRNA CTD PMID:12815608 menadione increases metabolic processing ISO RGD:737546 6480464 CBR1 protein results in increased metabolism of Vitamin K 3 CTD PMID:19061875 menadione multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Vitamin K 3], Vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 , PMID:23295225 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CBR1 mRNA CTD PMID:15644446 methylmercury chloride decreases expression ISO RGD:737546 6480464 methylmercuric chloride results in decreased expression of CBR1 mRNA CTD PMID:27188386 microcystin-LR increases expression ISO RGD:737547 6480464 cyanoginosin LR results in increased expression of CBR1 mRNA CTD PMID:17654400 monosodium L-glutamate increases activity ISO RGD:737547 6480464 Sodium Glutamate results in increased activity of CBR1 protein CTD PMID:25473020 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of CBR1 mRNA CTD PMID:16525678 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CBR1 mRNA CTD PMID:19638242 N-nitrosodiethylamine increases expression ISO RGD:737547 6480464 Diethylnitrosamine results in increased expression of CBR1 mRNA CTD PMID:12771043 , PMID:21607683 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of CBR1 mRNA CTD PMID:19716841 NADP zwitterion multiple interactions ISO RGD:737546 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 more ... NADP(+) multiple interactions ISO RGD:737546 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 more ... naphthalenes multiple interactions ISO RGD:737546 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of CBR1 protein CTD PMID:17337753 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CBR1 mRNA CTD PMID:24136188 nefazodone multiple interactions ISO RGD:737546 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of CBR1 mRNA CTD PMID:24136188 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of CBR1 mRNA CTD PMID:19483382 oxcarbazepine increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of oxcarbazepine CTD PMID:25063510 paracetamol decreases expression ISO RGD:737546 6480464 Acetaminophen results in decreased expression of CBR1 mRNA CTD PMID:22230336 , PMID:29067470 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CBR1 mRNA CTD PMID:18246545 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CBR1 mRNA CTD PMID:18246545 pentachlorophenol increases expression ISO RGD:737547 6480464 Pentachlorophenol results in increased expression of CBR1 mRNA CTD PMID:23892564 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CBR1 mRNA CTD PMID:19162173 phenobarbital increases expression ISO RGD:737547 6480464 Phenobarbital results in increased expression of CBR1 mRNA CTD PMID:19482888 , PMID:23091169 phenobarbital multiple interactions ISO RGD:737547 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CBR1 mRNA] CTD PMID:19482888 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:737546 6480464 CBR1 protein modified form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B mRNA] more ... CTD PMID:25818598 phorone affects expression EXP 6480464 phorone affects the expression of CBR1 mRNA CTD PMID:18198479 pirinixic acid increases expression ISO RGD:737547 6480464 pirinixic acid results in increased expression of CBR1 mRNA CTD PMID:18301758 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CBR1 mRNA CTD PMID:19162173 , PMID:22484513 pirinixic acid multiple interactions ISO RGD:737547 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CBR1 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of CBR1 mRNA] CTD PMID:19710929 , PMID:20059764 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CBR1 mRNA CTD PMID:19483382 potassium chromate increases expression ISO RGD:737546 6480464 potassium chromate(VI) results in increased expression of CBR1 mRNA CTD PMID:22714537 propiconazole increases expression ISO RGD:737547 6480464 propiconazole results in increased expression of CBR1 mRNA CTD PMID:21278054 quercetin multiple interactions ISO RGD:737546 6480464 [Quercetin co-treated with NADP] binds to CBR1 protein more ... CTD PMID:11306090 more ... rac-lactic acid decreases expression ISO RGD:737546 6480464 Lactic Acid results in decreased expression of CBR1 mRNA CTD PMID:30851411 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of CBR1 mRNA CTD PMID:18299717 resveratrol multiple interactions ISO RGD:737546 6480464 [resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin more ... CTD PMID:24064738 , PMID:24975222 resveratrol multiple interactions ISO RGD:737547 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA] CTD PMID:31298478 resveratrol affects binding ISO RGD:737546 6480464 CBR1 protein binds to resveratrol CTD PMID:24064738 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CBR1 mRNA CTD PMID:28374803 rutin multiple interactions ISO RGD:737546 6480464 Rutin binds to and results in decreased activity of CBR1 protein, Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 , PMID:18579125 S-nitrosoglutathione multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1 more ... CTD PMID:21256830 , PMID:23295225 S-nitrosoglutathione increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of S-Nitrosoglutathione CTD PMID:21256830 SB 431542 multiple interactions ISO RGD:737546 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 sodium arsenite increases expression ISO RGD:737546 6480464 sodium arsenite results in increased expression of CBR1 mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite multiple interactions ISO RGD:737546 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CBR1 protein CTD PMID:29459688 sodium dichromate decreases expression ISO RGD:737547 6480464 sodium bichromate results in decreased expression of CBR1 mRNA CTD PMID:22155349 sophoraflavanone B multiple interactions ISO RGD:737546 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 streptozocin decreases activity EXP 6480464 Streptozocin results in decreased activity of CBR1 protein CTD PMID:11057757 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of CBR1 protein CTD PMID:26141394 tebufenpyrad decreases expression ISO RGD:737546 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CBR1 mRNA CTD PMID:33512557 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA CTD PMID:26496021 testosterone enanthate affects expression ISO RGD:737546 6480464 testosterone enanthate affects the expression of CBR1 mRNA CTD PMID:17440010 tetrachloroethene increases expression ISO RGD:737547 6480464 Tetrachloroethylene results in increased expression of CBR1 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:737547 6480464 Carbon Tetrachloride results in increased expression of CBR1 mRNA CTD PMID:27339419 tetrachloromethane affects expression ISO RGD:737547 6480464 Carbon Tetrachloride affects the expression of CBR1 mRNA CTD PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CBR1 mRNA CTD PMID:30723492 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] CTD PMID:31150632 thalidomide decreases expression ISO RGD:737547 6480464 Thalidomide results in decreased expression of CBR1 mRNA CTD PMID:26217789 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of CBR1 mRNA CTD PMID:19483382 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CBR1 mRNA CTD PMID:23411599 tiaprofenic acid increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of tiaprofenic acid CTD PMID:28322780 titanium dioxide increases expression ISO RGD:737547 6480464 titanium dioxide results in increased expression of CBR1 mRNA CTD PMID:23131501 , PMID:31298478 titanium dioxide multiple interactions ISO RGD:737547 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CBR1 mRNA] CTD PMID:31298478 triclosan multiple interactions ISO RGD:737546 6480464 [Triclosan co-treated with NADP] binds to CBR1 protein CTD PMID:25526675 undecane increases expression EXP 6480464 undecane results in increased expression of CBR1 protein CTD PMID:17337753 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CBR1 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:737546 6480464 Valproic Acid results in decreased methylation of CBR1 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:737546 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737546 6480464 Valproic Acid results in increased expression of CBR1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:737547 6480464 Valproic Acid affects the expression of CBR1 mRNA CTD PMID:17292431 valproic acid affects expression ISO RGD:737546 6480464 Valproic Acid affects the expression of CBR1 mRNA CTD PMID:25979313 vancomycin increases expression ISO RGD:737547 6480464 Vancomycin results in increased expression of CBR1 mRNA CTD PMID:18930951 xanthohumol multiple interactions ISO RGD:737546 6480464 xanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 zoledronic acid decreases expression ISO RGD:737546 6480464 zoledronic acid results in decreased expression of CBR1 mRNA CTD PMID:24714768
